APEX

APEX interventional fellows course

Next course

Date

21st-23rd June 2024

Venue

Oxford

20-25 people

2.5 days

Why should you participate in this course?

The APEX interventional fellows’ course is a highly interactive residential course including case-based sessions, educational simulation skill workshops and didactic presentations.

With a highly experienced faculty in both PCI cases and delivering educational workshops you will be learning from the best.

Outline agenda

It’s a life-time of personalised PCI experience shared by expert operators – the course gives you direct exposure to case examples and solutions that you might otherwise never encounter.

Definitely the best course ever attended. I will strongly recommend it to all interventional fellows nationally and internationally.

Brilliant course including high complexity cases explained simply and logically. Great teachers.

Faculty

Dr Peter Okane Headshot

Dr Peter O’Kane

Bournemouth

Dr O’Kane graduated from Charing Cross and Westminster Medical School in 1995 with First Class Honours Bachelor of Science BSc degree in Physiology, Medical Degree and numerous prizes including the Llewelyn Prize for the second-best distinction in medical finals.

After attaining membership of the Royal College of Physicians he was subsequently awarded a Doctorate of Medicine by the University of London for a thesis on the role of nitric oxide in coronary heart disease.

Dr O’Kane was appointed as Consultant Interventional Cardiologist at the Royal Bournemouth Hospital in July 2007. He has performed over 7000 PCI procedures as a Consultant. He routinely treats extensively calcified lesions, bifurcations including left main stem disease and chronic total occlusions.

He is committed to teaching and education with local fellowship training programs through to national and international proctorship of techniques and multiple adjunctive devices. He has trained Consultant colleagues from the UK, Europe, Asia and USA through local workshops and courses. He is regularly invited as faculty to national and international meetings as a presenter and live case operator.

He has published over 80 manuscripts and authored 12 book chapters. He is a local principal Investigator for over 35 national and international multi-centre clinical trials and is dedicated to patient recruitment with over 1000 patients recruited to trials he has managed.

He has led numerous quality improvement programs, is PCI Lead, Cardiology Research Lead, Cardiology Governance and Cardiology Mortality Lead. He has achieved National Bronze Clinical Excellence Award level 9. He was a nationally elected member to British Cardiovascular Intervention Society (BCIS) Council (2020-2023) and since March 2023 is a member of BCIS Research Working Group.

Dr Jehangir Din

Dr Jehangir Din

Dorset

Dr Din is an interventional cardiologist at the Royal Bournemouth Hospital and Clinical Director for Cardiology across University Hospitals Dorset. He completed his undergraduate medical training at the University of Edinburgh, and then undertook his cardiology training at Edinburgh Heart Centre.

He completed the British Cardiovascular Intervention Society Vancouver Island PCI Fellowship before being appointed as a consultant in Bournemouth in 2012. He is a committed to PCI education and training, and as well as training many interventional fellows in Bournemouth, he also contributes to consultant training both nationally and internationally.

apex fellows tom johnson headshot

Dr Tom Johnson

Bristol

Dr Johnson, is Associate Professor of cardiology at the University of Bristol and consultant cardiologist at the Bristol Heart Institute. He has particular interests in intracoronary imaging, bifurcation PCI and simulation-based learning.

He is currently leading a 2000 patient prospective registry of OCT-guided PCI and is a board member of both the European Bifurcation Club & EuroPCR.

apex fellows divaka perera headshot

Prof Divaka Perera

London

Prof. Perera is an interventional cardiologist at St Thomas’ Hospital in London and a Professor of Cardiology at King’s College London. He was promoted to reader in interventional cardiology in 2013 and to professor of cardiology at Kings College in 2017. He teaches undergraduate medical students and supervises postgraduate researchers completing MSc, MD and PhD degrees at Kings College, London.

His specialist clinical interests synergise with his translational research programme, which is aimed at gaining novel insights into the mechanisms and consequences of ischaemia in order to develop effective treatments.

The main areas of research are development and validation of indices of epicardial and microvascular coronary disease, the biology and treatment of ischaemic cardiomyopathy and evaluating mechanical circulatory support strategies to prevent and treat shock.

The methodology used by his group ranges from detailed in vivo clinical physiological evaluation to developing and conducting multi-centre clinical trials.

apex fellows elliot smith headshot

Dr Elliot Smith

London

Dr Smith is a Consultant Cardiologist at Barts Heart Centre and Royal Free Hospitals, London, where he is the Lead for Higher Risk Revascularisation and CTO PCI.
He is an honorary consultant at Hammersmith Hospital and Great Ormond Street. He was previously Director of Interventional Training at Barts. He has an international reputation in the field of complex coronary interventions and chronic occlusions. He has been a proctor for CTO since 2013, regularly participating in live case demonstrations nationally and internationally.
Committed to interventional training and education, he is a course director and faculty for key international meetings, but actually likes the sound of his own voice slightly less than you might imagine!

Course disclaimer
For further details please contact: enquiries@vpmed.co.uk
All information provided is for the purpose of general guidance, we make no guarantees that you will obtain a particular outcome.
The course material is copyrighted and cannot be reproduced without written permission from VP MED Group.